A Refined Risk Score for Acute Graft-versus-Host Disease that Predicts Response to Initial Therapy, Survival, and Transplant-Related Mortality

This publication has 20 references indexed in Scilit:

• Discovery and validation of graft-versus-host disease biomarkers
  Blood, 2013
• Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study
  Blood, 2012
• What predicts high risk acute graft‐versus‐host disease (GVHD) at onset?: identification of those at highest risk by a novel acuteGVHDrisk score
  British Journal of Haematology, 2012
• Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network
  Blood, 2009
• Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
  Statistics in Medicine, 2007
• Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Societe Francaise de Greffe de Moelle et Therapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study
  Blood, 2005
• Comparison of the classic Glucksberg criteria and the IBMTR Severity Index for grading acute graft-versus-host disease following HLA-identical sibling stem cell transplantation
  Bone Marrow Transplantation, 1999
• A Proportional Hazards Model for the Subdistribution of a Competing Risk
  Journal of the American Statistical Association, 1999
• IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE
  British Journal of Haematology, 1997
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958